跳至主要内容
临床试验/NL-OMON38319
NL-OMON38319撤回不适用

Biomarker Expression, predicts risk of re-AMputation, impaired woundhealing and secundairy systemic cardiovascualr events, in patients with endstage peripheral atherosclerotic disease undergoing leg amputation due to advanced atherosclerotic disease. The BEAM study. - Biomarkers and risk of re-AMputation and systemic cardiovascular events

niversitair Medisch Centrum Utrecht0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients between 18-99 years old with critical limb ischemia and without medical treatment options, revascularization possibilities or exercise treatment.

排除标准

  • Younger than 18 years old, HIV positive patients

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验